Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
BioHarvest Sciences ( (BHST) ) has shared an announcement.
BioHarvest Sciences reported a boardroom reshuffle tied to a material change dated March 3, 2025, disclosed in a March 6, 2026 filing. The company announced that long-serving director David Tsur, who had been on the board since 2021, resigned and was immediately replaced by Prof. Hezi Levy.
Prof. Levy, a former Director General of Israel’s Ministry of Health, brings extensive leadership experience from overseeing national health policy during the COVID-19 pandemic and managing major medical institutions. His appointment signals a strategic move to deepen healthcare governance expertise at BioHarvest, with potential implications for its regulatory navigation and industry positioning.
The most recent analyst rating on (BHST) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on BioHarvest Sciences stock, see the BHST Stock Forecast page.
Spark’s Take on BHST Stock
According to Spark, TipRanks’ AI Analyst, BHST is a Neutral.
The score is held down primarily by weak financial performance (ongoing net losses, negative operating/free cash flow, and elevated leverage) and bearish technicals (below key moving averages with negative MACD). The latest earnings call adds support via strong revenue growth, improving gross margins, and guidance pointing toward adjusted EBITDA breakeven, but valuation remains constrained by unprofitability and no dividend.
To see Spark’s full report on BHST stock, click here.
More about BioHarvest Sciences
BioHarvest Sciences Inc. is a Vancouver-based company listed in the U.S. as a foreign private issuer. Operating in the broader life sciences and health-related technology space, it focuses on commercializing innovations that intersect biotechnology and healthcare markets. The company targets global health and wellness applications, positioning itself within highly regulated medical and consumer sectors.
Average Trading Volume: 40,974
Technical Sentiment Signal: Buy
Current Market Cap: $94.02M
For a thorough assessment of BHST stock, go to TipRanks’ Stock Analysis page.